CHASE ANTHONY R

Average Profitability
19.12%
Insider Buys Quantity
14
Insider Buys Sum
$970,378.25
Insider Sells Quantity
7
Insider Sells Sum
$1.03M

Insider Activity of CHASE ANTHONY R

The largest purchase of all time was on 2013-06-14 and amounted to 10000 shares of Sarepta Therapeutics, Inc. for $385,043.

The largest sale of all time was on 2012-09-07 and amounted to 33000 shares of Sarepta Therapeutics, Inc. for $476,959.

Biography of CHASE ANTHONY R

No biography is available at this moment.

2023-04-25SaleLyondellBasell Industries N.V.
LYB
director
1
<0.0001%
$91.36$91+5.59%
2022-12-06PurchaseLyondellBasell Industries N.V.
LYB
director
1
<0.0001%
$82.30$82+15.06%
2022-10-03SaleLyondellBasell Industries N.V.
LYB
director
10
<0.0001%
$78.22$782
2022-09-01PurchaseLyondellBasell Industries N.V.
LYB
director
10
<0.0001%
$81.86$819+13.47%
2022-07-26SaleLyondellBasell Industries N.V.
LYB
director
25
<0.0001%
$87.56$2,189+5.21%
2022-06-23PurchaseCullen/Frost Bankers, Inc.
CFR
director
1
<0.0001%
$109.00$109+15.33%
2022-06-23PurchaseLyondellBasell Industries N.V.
LYB
director
2
<0.0001%
$84.50$169+5.61%
2021-12-10PurchaseLyondellBasell Industries N.V.
LYB
director
25
<0.0001%
$89.91$2,248+6%
2013-11-14PurchaseSarepta Therapeutics, Inc.
SRPT
director
10,000
0.0286%
$13.95$139,483+59.16%
2013-08-22PurchaseSarepta Therapeutics, Inc.
SRPT
director
3,500
0.0104%
$32.68$114,373-14.65%
2013-06-14PurchaseSarepta Therapeutics, Inc.
SRPT
director
10,000
0.0313%
$38.50$385,043-15.43%
2012-11-28SaleSarepta Therapeutics, Inc.
SRPT
director
8,900
0.0273%
$29.52$262,689+14.7%
2012-11-27SaleSarepta Therapeutics, Inc.
SRPT
director
1,100
0.0035%
$29.04$31,940+20.49%
2012-11-14SaleSarepta Therapeutics, Inc.
SRPT
director
10,000
0.032%
$25.70$257,002+37.06%
2012-09-07SaleSarepta Therapeutics, Inc.
SRPT
director
33,000
0.1399%
$14.45$476,959+107.97%
2011-09-13PurchaseSarepta Therapeutics, Inc.
SRPT
director
20,000
0.015%
$1.20$24,000-22.88%
2010-06-09PurchaseSarepta Therapeutics, Inc.
SRPT
director
46,500
0.0449%
$1.42$65,889+41.35%
2010-05-21PurchaseSarepta Therapeutics, Inc.
SRPT
director
50,000
0.045%
$1.33$66,500+40.3%
2010-05-18PurchaseSarepta Therapeutics, Inc.
SRPT
director
11,068
0.0101%
$1.44$15,923+31.47%
2010-05-17PurchaseSarepta Therapeutics, Inc.
SRPT
director
18,539
0.0168%
$1.41$26,140+33.33%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.